S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
Critical asset just had biggest fall on record (Ad)
Norway's hospitalized king gets a pacemaker in Malaysia after falling ill during vacation
Sports analytics may be outnumbered when it comes to artificial intelligence
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
South Korean doctors hold massive anti-government rally over medical school recruitment plan
What to watch for as China's major political meeting of the year gets underway
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
Critical asset just had biggest fall on record (Ad)
Norway's hospitalized king gets a pacemaker in Malaysia after falling ill during vacation
Sports analytics may be outnumbered when it comes to artificial intelligence
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
South Korean doctors hold massive anti-government rally over medical school recruitment plan
What to watch for as China's major political meeting of the year gets underway
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
Critical asset just had biggest fall on record (Ad)
Norway's hospitalized king gets a pacemaker in Malaysia after falling ill during vacation
Sports analytics may be outnumbered when it comes to artificial intelligence
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
South Korean doctors hold massive anti-government rally over medical school recruitment plan
What to watch for as China's major political meeting of the year gets underway
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
Critical asset just had biggest fall on record (Ad)
Norway's hospitalized king gets a pacemaker in Malaysia after falling ill during vacation
Sports analytics may be outnumbered when it comes to artificial intelligence
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
South Korean doctors hold massive anti-government rally over medical school recruitment plan
What to watch for as China's major political meeting of the year gets underway
NYSE:BHC

Bausch Health Companies (BHC) Stock Price, News & Analysis

$9.89
+0.50 (+5.32%)
(As of 03/1/2024 ET)
Today's Range
$9.29
$9.90
50-Day Range
$7.45
$9.89
52-Week Range
$5.57
$10.15
Volume
5.99 million shs
Average Volume
2.34 million shs
Market Capitalization
$3.61 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$11.50

Bausch Health Companies MarketRank™ Stock Analysis

Analyst Rating
Hold
2.33 Rating Score
Upside/​Downside
16.3% Upside
$11.50 Price Target
Short Interest
Bearish
6.03% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.42
Upright™ Environmental Score
News Sentiment
0.76mentions of Bausch Health Companies in the last 14 days
Based on 4 Articles This Week
Insider Trading
Selling Shares
$1,624 Sold Last Quarter
Proj. Earnings Growth
1.81%
From $3.86 to $3.93 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.30 out of 5 stars

Medical Sector

325th out of 951 stocks

Pharmaceutical Preparations Industry

144th out of 424 stocks

BHC stock logo

About Bausch Health Companies Stock (NYSE:BHC)

Bausch Health Companies Inc. operates as a diversified pharmaceutical company. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, and eye health. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products in the United States. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products internationally. The Solta Medical segment engages in the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; generic products; ortho dermatologic; and dentistry products in the United States. The Bausch + Lomb segment offers products in the areas of vision care, surgical, and ophthalmic pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. was incorporated in 2013 and is headquartered in Laval, Canada.

BHC Stock Price History

BHC Stock News Headlines

This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
Are Medical Stocks Lagging Bausch Health (BHC) This Year?
Are Medical Stocks Lagging Bausch Health (BHC) This Year?
See More Headlines
Receive BHC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bausch Health Companies and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/22/2024
Today
3/03/2024
Next Earnings (Estimated)
5/02/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Employees
19,900
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$11.50
High Stock Price Target
$14.00
Low Stock Price Target
$9.00
Potential Upside/Downside
+16.3%
Consensus Rating
Hold
Rating Score (0-4)
2.33
Research Coverage
3 Analysts

Profitability

Net Income
$-592,000,000.00
Pretax Margin
-4.45%

Debt

Sales & Book Value

Annual Sales
$8.76 billion
Cash Flow
$7.61 per share
Book Value
($0.22) per share

Miscellaneous

Free Float
315,168,000
Market Cap
$3.61 billion
Optionable
Optionable
Beta
0.83
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

  • Mr. Thomas J. Appio (Age 62)
    CEO & Director
    Comp: $4.73M
  • Ms. Seana  CarsonMs. Seana Carson (Age 52)
    Executive VP & General Counsel
    Comp: $720.5k
  • Mr. John S. Barresi (Age 51)
    Senior VP, Controller, Chief Accounting Officer & Interim CFO
  • Mr. Mirza Dautbegovic
    Senior VP & COO
  • Mr. Josh Coyle
    Senior Vice President of Sales & Salix
  • Ms. Kathleen Fitzpatrick
    Senior VP & Chief HR Officer
  • Dr. Tage Ramakrishna M.D. (Age 50)
    Chief Medical Officer and President of R&D
  • Mr. Jeff Hartness
    Executive VP of Market Access, Commercial Operations, Neurology, Generics & Government Affairs
  • Dr. Graham Jackson
    Senior VP & Chief Quality Officer
  • Mr. Cees Heiman
    Senior Vice President of Europe & Canada














BHC Stock Analysis - Frequently Asked Questions

Should I buy or sell Bausch Health Companies stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Bausch Health Companies in the last twelve months. There are currently 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" BHC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in BHC, but not buy additional shares or sell existing shares.
View BHC analyst ratings
or view top-rated stocks.

What is Bausch Health Companies' stock price target for 2024?

3 analysts have issued 1 year price objectives for Bausch Health Companies' stock. Their BHC share price targets range from $9.00 to $14.00. On average, they anticipate the company's share price to reach $11.50 in the next year. This suggests a possible upside of 16.3% from the stock's current price.
View analysts price targets for BHC
or view top-rated stocks among Wall Street analysts.

How have BHC shares performed in 2024?

Bausch Health Companies' stock was trading at $8.02 on January 1st, 2024. Since then, BHC shares have increased by 23.3% and is now trading at $9.89.
View the best growth stocks for 2024 here
.

When is Bausch Health Companies' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024.
View our BHC earnings forecast
.

How were Bausch Health Companies' earnings last quarter?

Bausch Health Companies Inc. (NYSE:BHC) released its earnings results on Thursday, February, 22nd. The company reported $1.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.01 by $0.14. The business had revenue of $2.41 billion for the quarter, compared to analyst estimates of $2.29 billion. Bausch Health Companies had a positive trailing twelve-month return on equity of 5,147.48% and a negative net margin of 6.76%. The business's revenue for the quarter was up 9.8% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.02 EPS.

What guidance has Bausch Health Companies issued on next quarter's earnings?

Bausch Health Companies issued an update on its FY 2024 earnings guidance on Thursday, February, 22nd. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $9.3 billion-$9.3 billion, compared to the consensus revenue estimate of $9.0 billion.

What is Joseph C. Papa's approval rating as Bausch Health Companies' CEO?

43 employees have rated Bausch Health Companies Chief Executive Officer Joseph C. Papa on Glassdoor.com. Joseph C. Papa has an approval rating of 97% among the company's employees. This puts Joseph C. Papa in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Bausch Health Companies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Bausch Health Companies investors own include Gilead Sciences (GILD), Micron Technology (MU), Constellation Software (CSU), Intact Financial (IFC), NVIDIA (NVDA), Netflix (NFLX), Alibaba Group (BABA), Tesla (TSLA), Advanced Micro Devices (AMD) and Bank of America (BAC).

Who are Bausch Health Companies' major shareholders?

Bausch Health Companies' stock is owned by a number of retail and institutional investors. Top institutional shareholders include National Bank of Canada FI (4.34%), Nomura Holdings Inc. (3.68%), Healthcare of Ontario Pension Plan Trust Fund (3.60%), Royal Bank of Canada (3.25%), Vanguard Group Inc. (3.21%) and Citadel Advisors LLC (0.00%). Insiders that own company stock include Amy B Wechsler, Christina Ackermann, Joseph F Gordon, Robert Spurr, Russell Barrans, Sam Eldessouky, Schutter Richard U De, Seana Carson and Steven D Miller.
View institutional ownership trends
.

How do I buy shares of Bausch Health Companies?

Shares of BHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:BHC) was last updated on 3/3/2024 by MarketBeat.com Staff

From Our Partners